Cite
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.
MLA
Vaidya, Vishal S., et al. “Kidney Injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies.” Nature Biotechnology, vol. 28, no. 5, May 2010, pp. 478–85. EBSCOhost, https://doi.org/10.1038/nbt.1623.
APA
Vaidya, V. S., Ozer, J. S., Dieterle, F., Collings, F. B., Ramirez, V., Troth, S., Muniappa, N., Thudium, D., Gerhold, D., Holder, D. J., Bobadilla, N. A., Marrer, E., Parentes, E., Cordier, A., Vonderscher, J., Maurer, G., Goering, P. L., Sistare, F. D., & Bonventre, J. V. (2010). Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nature Biotechnology, 28(5), 478–485. https://doi.org/10.1038/nbt.1623
Chicago
Vaidya, Vishal S., Josef S. Ozer, Frank Dieterle, Fitz B. Collings, Victoria Ramirez, Sean Troth, Nagaraja Muniappa, et al. 2010. “Kidney Injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies.” Nature Biotechnology 28 (5): 478–85. doi:10.1038/nbt.1623.